Contraceptive Options for the Patient with Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension

¹ 

关键词: Cardiology;    Rheumatology;    Pediatrics;    WHO Group 1- Pulmonary Arterial Hypertension;    PH Medications;    Anatomy;    Physiology/Pathophysiology;    symptoms;    Gender;    PH;    Neonatal;    Associated Diseases;    Congenital Heart Disease;    Systolic dysfunction;    Oral therapy;    IV therapy;    Phosphodiesterase Inhibitors (PDE-5 Inhibitors);    Prostacyclin;    Endothelin Receptor Antagonists;    pharmacokinetics;    nitric oxide;    Anticoagulation;    Inotropes;    Pulmonary vascular resistance;    Cardiac Index;    Fick;    Thermodilution;    endothelial dysfunction;    Pregnancy;    Contraceptives;    Estrogen;    Testosterone;    Drug development;    Side Effects;    pre-clinical research;    CME;    Anesthesia;    Classification;    Epidemiology;   

DOI  :  

学科分类：医学（综合）

来源: Pulmonary Hypertension Association

【 摘 要 】

Unintended pregnancies continue to occur at an astronomically high rate in the US, as high as 35% by most recent data,2 and of course, since women with pulmonary arterial hypertension (PAH) are not exempt from this statistic, it is imperative that as care providers, we help our patients to plan ahead. In their case, maternal health is our main concern.

【 授权许可】

All Rights reserved